Oral Delivery of Bioencapsulated CTB-Pro-IGF-1 Enhances Bone Regeneration in a Pre-Clinical Rat Model of Jaw Osteoradionecrosis.
Аннотация
OBJECTIVE
Head and neck cancer radiotherapy can lead to jaw osteoradionecrosis (ORN). There is currently no definitive treatment for ORN. The efficacy of a novel orally delivered aglycosylated IGF-1 with an E-peptide (CTB-Pro-IGF-1), bioencapsulated in plant cells, was evaluated as therapy for jaw ORN in rats.
MATERIALS AND
METHODS
Rat jaw ORN was induced with 50 Gy radiation and minor trauma. CTB-Pro-IGF-1 expression in lettuce chloroplasts was assessed, and pharmacokinetic analyses were used to determine therapeutic dosage. Irradiated and control rats received oral gavage of 560 μg of CTB-Pro-IGF-1 daily for 2 weeks. Bone regeneration was evaluated using in vivo microCT, ex vivo microCT, and histological analyses.
RESULTS
CTB-Pro-IGF-1 expression in lettuce increased with age (52, 60, and 72 days; p < 0.05) and was stable across several generations (T2, T3; p < 0.05). CTB-Pro-IGF-1 reached maximum serum levels within 6 h, with elimination by 24 h, without altering endogenous IGF-1 levels. Histology and microCT analysis confirmed complete bone regeneration in the treated animals compared with untreated animals.
CONCLUSION
CTB-Pro-IGF-1 bioencapsulated in plant cells enhanced bone regeneration and healing in a pre-clinical rat jaw ORN, showing potential as a novel, affordable oral treatment for ORN complications in head and neck radiotherapy.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.